British Bio-technology Group plc announced Friday it has begunPhase I clinical trials for BB-882, an oral treatment for asthma.The company had previously announced that trials were tobegin in the fall. British Bio-technology of Oxford, England, hasbeen granted a notice of allowance for a U.S. patent coveringBB-882, and expects the patent to be issued in the next fewmonths.

(c) 1997 American Health Consultants. All rights reserved.